Chinese version of Website (中国版网站)
Search
Advanced Search
Chinese version of Website (中国版网站)
Toggle navigation
Home
Journals & eBooks
Browse Journals by Subject
Browse Journals by Title
Browse Patent Journals
Free Online Samples
Journals Impacting Science
New Titles 2019
Price and Ordering Information
Subscription Rates 2018
Subscription Rates 2017
Browse eBooks by Subject
Browse eBooks by Title
Browse Video Books
eBooks Website
Journals and eBooks Catalog
Free Online Trials
Endorsements
Articles by Disease
Bentham Online
Bentham Insight
Online Feedback
Purchase Articles
Search Articles
Social Media
Submit Manuscripts
Marketing Opportunities
Advertise With Us
Journals and eBooks Catalog
Media-Pack-2018
Author's Benefits Guide
Events by Region
Events by Subject Areas
Exhibit Schedule
Healthcare Industry Resources
Kudos
Media Partners
Partnering Events
For Librarians
FAQ’s for e-prints/reprints
Journal Catalog 2018
Library Recommendations
Order Bulk ePrints
Order Bulk Reprints
Table of Contents Alert
Trial Requests
For Authors & Editors
Author Benefits
Author's Benefits Guide
Editorial Policies
General FAQ’s
Guidelines for Guest Editors
Online Manuscript Submission
Journal Catalog 2018
Publication Cycle - Process Flowchart
Publishing Ethics
Reviewer Guidelines
Self-Archiving Policies
Table of Contents Alert
Contact
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
Volume 15, 12 Issues, 2018
Download PDF Flyer
Letters in Drug Design & Discovery
This journal supports open access
Impact Factor:
1.17
5 - Year Impact Factor:
0.84
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
Submit Manuscripts Online
Editor-in-Chief:
George Perry
University of Texas
San Antonio, TX
USA
View Full Editorial Board
Subscribe
Purchase Articles
Order Reprints
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Open Access Articles
Most Accessed Articles
Most Cited Articles
Advertise With Us
Library Recommendation
Trial Requests
More Options
Special Issue Submission
Open Access Funding
Advertisement
ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)
Volume 15, 12 Issues, 2018
Download PDF Flyer
Letters in Drug Design & Discovery
This journal supports open access
Impact Factor:
1.17
5 - Year Impact Factor:
0.84
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
Submit Manuscripts Online
Editor-in-Chief:
George Perry
University of Texas
San Antonio, TX
USA
View Full Editorial Board
Subscribe
Purchase Articles
Order Reprints
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Open Access Articles
Most Accessed Articles
Most Cited Articles
Advertise With Us
Library Recommendation
Trial Requests
More Options
Special Issue Submission
Open Access Funding
Letters in Drug Design & Discovery
This journal supports open access
Quick Links
Journal Home
Editorial Policies
Publishing Ethics
Self-Archiving Policies
Reviewer Guidelines
Instructions for Authors
Free Copies Online
Contents & Abstracts
Open Access Articles
Most Accessed Articles
Most Cited Articles
Advertise With Us
Library Recommendation
Trial Requests
Special Issue Submission
Open Access Funding
Impact Factor:
1.17
5 - Year Impact Factor:
0.84
Aims & Scope
Abstracted/Indexed in
Submit Abstracts Online
More Options
Submit Manuscripts Online
Editor-in-Chief:
George Perry
University of Texas
San Antonio, TX
USA
View Full Editorial Board
Subscribe
More Options
Purchase Articles
Order Reprints
Contents
Letters in Drug Design & Discovery
,
Volume 2
- Number 8
Rational Design of the New Antihypertensive I1-Receptor Ligand 2-(2- Biphenyl-2-yl-1-methyl-ethyl)-4,5-dihydro-1H-imidazole
,
2
(
8
):
571
- 578
F. Gentili, P. Bousquet, A. Carrieri, J. Feldman, F. Ghelfi, M. Giannella, A. Piergentili, W. Quaglia, C. Vesprini and M. Pigini
DOI:
10.2174/157018005774717325
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Docking Study, Synthesis and SAH-Hydrolase Inhibitory Activity of LAdeninylalanine and Related Analogues
,
2
(
8
):
579
- 583
Nicolas Floquet, Samuel Leroy, Murielle Muzard, Georges Guillerm and Jean-Bernard Behr
DOI:
10.2174/157018005774717262
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Anti-tumour Activity of Some Polydentate N-Ligands: N,N-bis-(3- Substituted-5-Methylpyrazol-1yl Methyl) Arylamines and N,N,N,N-Tetra- [(3-Substituted-5-Methylpyrazol-1yl] Para-Phenylenediamines
,
2
(
8
):
584
- 589
T. B. Hadda, A. T. Kotchevar, M. Daoudi, B. Bennani, N. B. Larbi and A. Kerbal
DOI:
10.2174/157018005774717299
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Discovery of Thrombin Inhibitor Fragments from Chemical Microarray Screening
,
2
(
8
):
590
- 594
Thomas Neumann, Hans-Dieter Junker, Oliver Keil, Klaus Burkert, Holger Ottleben, Jurgen Gamer, Renate Sekul, Holger Deppe, Achim Feurer, Dirk Tomandl and Gunther Metz
DOI:
10.2174/157018005774717343
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Identification of Privileged Scaffolds from a Diversified Chemical Library forβ-Secretase Inhibition
,
2
(
8
):
595
- 600
Nicolas Pietrancosta, Gilles Quelever, Cedrik Garino, Younes Laras, Stephane Burlet and Jean-Louis Kraus
DOI:
10.2174/157018005774717352
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Synthesis and Biological Evaluation of 1,2,4-Triazolo[2,3-a]pyrrole Derivatives as Alpha-4 ( α4) Integrin Antagonists
,
2
(
8
):
601
- 605
Edward C. Lawson, William A. Kinney, Rosemary J. Santulli, Carol M. Fisher, Bruce P. Damiano and Bruce E. Maryanoff
DOI:
10.2174/157018005774717280
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Szeged Index - Applications for Drug Modeling
,
2
(
8
):
606
- 624
Padmakar V. Khadikar, Sneha Karmarkar, Vijay K. Agrawal, Jyoti Singh, Anjali Shrivastava, Istvan Lukovits and Mircea V. Diudea
DOI:
10.2174/157018005774717334
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Initial Structure-Activity Relationships for a Caprolactam-based Series of Neutral Factor Xa Inhibitors: Lead Identification
,
2
(
8
):
625
- 630
Gregory S. Bisacchi, Philip D. Stein, Jack Z. Gougoutas, Karen S. Hartl, R. Michael Lawrence, Eddie Liu, Andrew Pudzianowski, William A. Schumacher, Doree Sitkoff, Thomas E. Steinbacher, James Sutton, Zhaoxiao Zhang and Steven M. Seiler
DOI:
10.2174/157018005774717316
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Synthesis and Evaluation of p-Nitrophenylβ-D-Glucopyranosiduronic Analogues as New Triggers for β-Glucuronidase Mediated Prodrug Mono- Therapy
,
2
(
8
):
631
- 637
Damien Combaud, Mickael Thomas, Sebastien Papot and Jean-Pierre Gesson
DOI:
10.2174/157018005774717271
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Structure Based Design of Inhibitors of Aspartic Protease of HIV-1
,
2
(
8
):
638
- 646
V. Frecer, A. Jedinak, A. Tossi, F. Berti, F. Benedetti, D. Romeo and S. Miertus
DOI:
10.2174/157018005774717307
View Abstract
Permissions
Order Reprints
Order Eprints
View Abstract
Webmaster Contact:
info@benthamscience.org
Copyright © 2018 Bentham Science